EN DE

Streamex Corp (STEX) Fair Value & Analysis

Financial Services · US · Market cap $187M

SC Streamex Corp logo Streamex Corp STEX · US
Price$0.8332
Fair Value$0.6200
Upside-25.6%
Quality22/100
Watch Streamex Corp for free, get notified when fair value or trend changes. Watch for free

Risks

!Trades 26% ABOVE our fair value of $0.6200
!Weak Growth
!Thin margins · 0.0% net margin
!negative free cash flow
Weak Growth
Thin margins · 0.0% net margin
negative free cash flow
Trails peers (0/7)
Narrow moat 23/100
Evidence: Low Range $0.4700 – $0.7800 Share as image

Fair value as of: Aug 22, 2026

From 2 valuation models · updated today

Share price +9.3% over the past month.

Below-average quality, and screening another 26% overvalued on our models.

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Fair value for all 35,000+ stocks, review alerts and the diversification check: 14 days of Pro free, no card.

What matters now

  • The price sits above even our optimistic bull case ($0.7800). The favourable scenario is already priced in.
  • Weak quality (22/100) and above fair value at the same time, the margin of safety is missing on both counts.
  • Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
  • For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

$43.50 $0.2530 Fair Value $0.6200 May 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 22, 2026.

How to read this chart

60‑month range $0.2530 – $43.50 · fair‑value band $0.4700 – $0.7800 · the $0.8332 price screens above the $0.6200 fair value. Dashed = 300-day average. As of Aug 22, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Streamex Corp (STEX) currently trades at $0.8332, while our model-based Fair Value estimate is $0.6200, implying the stock looks roughly 25.6% overvalued today. The Quality Score stands at 22/100 (below-average quality), in the Financial Services sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).

Trailing-twelve-month revenue stands at $13.0K. Net debt stands at $17.7M. Fundamentals as of Aug 22, 2026

Our scenario range runs from $0.4700 (bear case) to $0.7800 (bull case); at $0.8332, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. For context, the median of 10 Financial Services peers we cover trades at -19% fair-value upside, at -26%, STEX screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
P/B Multiple $0.4700 $0.6200 $0.7800 55
NCAV (Graham) $0.3700 $0.4900 $0.7300 50
All 2 models by family
Multiples
P/B Multiple $0.4700 $0.6200 $0.7800 55
Asset-Based
NCAV (Graham) $0.3700 $0.4900 $0.7300 50

Widest divergence: Multiples ($0.6200) versus Asset-Based ($0.4900). Highest evidence: P/B Multiple (55).

Notify me when STEX reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) $13.0K
Return on equity -625%
Free cash flow −$10.4M FY2025
EPS (TTM) $-9.59
Net debt $17.7M FY2025

Figures from reported company fundamentals · as of Aug 22, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 22/100

Of which business quality 32 · Market factors (momentum, volatility) 3

Profitability 0
Margins and returns on capital today
Quality Growth 42
Are margins and returns improving?
Cashflow 50
Earnings quality: real cash, not paper profit
Fin. Strength 79
Balance sheet, leverage, solvency risk
Investment 0
Disciplined investing over empire-building
Low Volatility 0
Calm price path (market factor)
Momentum 6
Price trend over the last 3–12 months (market factor)
52W Momentum 1
Distance to the 52-week high (market factor)
Net Issuance 0
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Streamex Corp., a medical device technology company, provides advanced digital signal processing solutions for electrophysiology in the United States. The company offers the PURE EP platform, which delivers cardiac signal data to electrophysiologists during ablation procedures for the treatment of cardiovascular arrhythmias.

Full company description

Streamex Corp., a medical device technology company, provides advanced digital signal processing solutions for electrophysiology in the United States. The company offers the PURE EP platform, which delivers cardiac signal data to electrophysiologists during ablation procedures for the treatment of cardiovascular arrhythmias. It also develops and operates the Streamex Exchange platform, a blockchain-based platform that facilitates the tokenization and exchange of real-world assets for the tokenized gold market. In addition, the company offers software support, maintenance, and upgrade services. The company was formerly known as BioSig Technologies, Inc. and changed its name to Streamex Corp. in September 2025. Streamex Corp. was incorporated in 2009 and is headquartered in Winter Park, Florida.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Streamex Corp reported revenue of $0 in FY2025 versus $441K in FY2021. Reported net income was −$463M in FY2025.

Growth Quality 0/100
Revenue growth is weak, negative or inconsistent.
Latest Revenue (FY 2024)
$40.0K
Latest YoY
+122.2%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−55.1%
Revenue
FY21 $441K
FY22 $286K
FY23 $18.0K
FY24 $40.0K
FY25 $0
Net income
FY21 −$31.9M
FY22 −$27.1M
FY23 −$29.0M
FY24 −$10.3M
FY25 −$463M

STEX screens 26% overvalued. Compare with Mirae Asset Securities Co →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Streamex Corp Fair Value". https://www.fairvalue-calculator.com/stock/STEX

Peer Group

Capital Markets · 439 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 32 · Bottom 25%
Fair Value upside −26% · Below median
Return on assets -71% · Bottom 25%
Net margin (TTM) 0% · Bottom 25%
Operating margin (TTM) 0% · Bottom 25%
Revenue growth 0% · Below median

Valuation Multiples vs Capital Markets median · lower = cheaper

P/B 1.40× · Pricier than median

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Capital Markets stocks, each showing price versus our Fair Value estimate (as of Aug 22, 2026).

Stock Price Fair Value vs Fair Value
Mirae Asset Securities Co 006800 38,050 KRW 18,009 KRW -53%
Meritz Financial Group 138040 118,600 KRW 52,717 KRW -56%
Korea Investment Holdings 071050 200,500 KRW 189,335 KRW -6%
NH Investment & Securities Co 005940 28,550 KRW 22,396 KRW -22%
Samsung Securities Co 016360 93,100 KRW 75,573 KRW -19%
Kiwoom Securities Co 039490 299,000 KRW 214,812 KRW -28%
SSI Securities Corporation SSI 19,400 VND 17,375 VND -10%
Bolsas y Mercados Argentinos S.A BYMA 313.75 ARS 294.30 ARS -6%
Daishin Securities Co 003540 26,950 KRW 48,790 KRW +81%
SK Securities Co 001515 4,285 KRW 1,395 KRW -67%

Compare Streamex Corp with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Financial Services stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Discover undervalued stocks

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screener Filter by region, size and sector Compare tool Two stocks side by side Evidence & backtest 34 years, survivorship-adjusted Financial calculators DCF, Graham, PEG and more

Frequently asked questions

Is Streamex Corp (STEX) overvalued or undervalued?
As of Aug 22, 2026, our model estimates a fair value of $0.6200 versus a price of $0.8332, about −26% (overvalued).
What is the fair value of STEX?
Our model-based fair value for Streamex Corp is $0.6200 (as of Aug 22, 2026), built from audited fundamentals. The current price: $0.8332.
What is the quality score of STEX?
Streamex Corp has a Quality Score of 22/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Streamex Corp (STEX)?
Streamex Corp reported trailing-twelve-month revenue of about $13.0K (latest available figure, as of Aug 22, 2026).
What is the net profit margin of STEX?
The net profit margin of Streamex Corp is about 0.0%, meaning it keeps roughly 0.0% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Streamex Corp and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.